Product NDC: | 51991-651 |
Proprietary Name: | Levetiracetam |
Non Proprietary Name: | Levetiracetam |
Active Ingredient(s): | 100 mg/mL & nbsp; Levetiracetam |
Administration Route(s): | ORAL |
Dosage Form(s): | LIQUID |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 51991-651 |
Labeler Name: | Breckenridge Pharmaceutical, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA090461 |
Marketing Category: | ANDA |
Start Marketing Date: | 20101207 |
Package NDC: | 51991-651-16 |
Package Description: | 473 mL in 1 BOTTLE, PLASTIC (51991-651-16) |
NDC Code | 51991-651-16 |
Proprietary Name | Levetiracetam |
Package Description | 473 mL in 1 BOTTLE, PLASTIC (51991-651-16) |
Product NDC | 51991-651 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Levetiracetam |
Dosage Form Name | LIQUID |
Route Name | ORAL |
Start Marketing Date | 20101207 |
Marketing Category Name | ANDA |
Labeler Name | Breckenridge Pharmaceutical, Inc. |
Substance Name | LEVETIRACETAM |
Strength Number | 100 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |